CDC73 Gene Hyperparathyroidism type 1 familial Genetic Test
At DNA Labs UAE, we offer the CDC73 Gene Hyperparathyroidism type 1 familial Genetic Test at a cost of 4400.0 AED. This test is used to diagnose and identify the risk of developing hyperparathyroidism type 1, familial.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the CDC73 Gene Hyperparathyroidism type 1 familial Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the CDC73 Gene Hyperparathyroidism type 1 familial NGS Genetic DNA Test gene CDC73.
Test Details
The CDC73 gene, also known as the HRPT2 gene, is associated with a condition called hyperparathyroidism type 1, familial (HPT-JT). This condition is characterized by the development of parathyroid tumors, which can lead to overproduction of parathyroid hormone (PTH) and subsequent high levels of calcium in the blood (hypercalcemia).
NGS genetic testing refers to Next-Generation Sequencing, a technology used to analyze multiple genes simultaneously. In the context of hyperparathyroidism type 1, familial, NGS genetic testing can be used to identify mutations or variations in the CDC73 gene that may be responsible for the development of the condition.
By analyzing the CDC73 gene through NGS genetic testing, healthcare professionals can identify individuals who are at risk of developing hyperparathyroidism type 1, familial. This can help with early diagnosis, treatment planning, and genetic counseling for affected individuals and their families.
It’s important to note that NGS genetic testing for hyperparathyroidism type 1, familial should be conducted under the guidance of a healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.
| Test Name | CDC73 Gene Hyperparathyroidism type 1 familial Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CDC73 Gene Hyperparathyroidism type 1, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDC73 Gene Hyperparathyroidism type 1, familial NGS Genetic DNA Test gene CDC73 |
| Test Details |
The CDC73 gene, also known as the HRPT2 gene, is associated with a condition called hyperparathyroidism type 1, familial (HPT-JT). This condition is characterized by the development of parathyroid tumors, which can lead to overproduction of parathyroid hormone (PTH) and subsequent high levels of calcium in the blood (hypercalcemia). NGS genetic testing refers to Next-Generation Sequencing, a technology used to analyze multiple genes simultaneously. In the context of hyperparathyroidism type 1, familial, NGS genetic testing can be used to identify mutations or variations in the CDC73 gene that may be responsible for the development of the condition. By analyzing the CDC73 gene through NGS genetic testing, healthcare professionals can identify individuals who are at risk of developing hyperparathyroidism type 1, familial. This can help with early diagnosis, treatment planning, and genetic counseling for affected individuals and their families. It’s important to note that NGS genetic testing for hyperparathyroidism type 1, familial should be conducted under the guidance of a healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations based on the individual’s specific situation. |
